Guinee V F, Guido J J, Pfalzgraf K A, Giacco G G, Lagarde C, Durand M, van der Velden J W, Löwenberg B, Jereb B, Bretsky S
Cancer. 1985 Aug 1;56(3):642-8. doi: 10.1002/1097-0142(19850801)56:3<642::aid-cncr2820560334>3.0.co;2-n.
The incidence of zoster in 717 patients with Hodgkin's disease was determined by a retrospective chart review. All patients had been treated and followed in one of six cancer centers. Prognostic factors that might predict the subsequent incidence of zoster were examined by univariate and multivariate analytic techniques. Intensity of treatment was a key factor in the incidence of zoster. Thirty-six months after initiation of treatment, patients receiving chemotherapy-radiation-chemotherapy had twice the attack rate (27.3%) of those receiving radiation alone (11.5%). The pediatric age group had a significantly higher attack rate (26.6%) than did adults (18.7%). Stage, histology, and laparotomy did not influence the incidence of zoster.
通过回顾性病历审查确定了717例霍奇金病患者的带状疱疹发病率。所有患者均在六个癌症中心之一接受治疗和随访。采用单因素和多因素分析技术研究了可能预测带状疱疹后续发病率的预后因素。治疗强度是带状疱疹发病率的关键因素。治疗开始36个月后,接受化疗-放疗-化疗的患者发作率(27.3%)是仅接受放疗患者(11.5%)的两倍。儿童年龄组的发作率(26.6%)显著高于成人(18.7%)。分期、组织学和剖腹手术对带状疱疹的发病率没有影响。